Business
The Marquie Group Joins Forces with City of Hope to Combat Metastatic Triple-Negative Breast Cancer
ST. PETERSBURG, Fla., March 19, 2025 (GLOBE NEWSWIRE) -- The Marquie Group, Inc. (OTCMKTS: TMGI) is proud to announce that it is supporting Peter P. Lee, M.D., Chair of the Department of Immuno-Oncology at Beckman Research Institute at City of Hope, one of the largest and most advanced cancer research and treatment organizations in the United States, to raise awareness and funds for groundbreaking research on metastatic triple-negative breast cancer (mTNBC) using ivermectin. Through its subsidia
About this update from Transglobal Management Group, Inc.
[{"type":"text","content":"ST. PETERSBURG, Fla., March 19, 2025 (GLOBE NEWSWIRE) -- The Marquie Group, Inc. (OTCMKTS: TMGI) is proud to announce that it is supporting Peter P. Lee, M.D., Chair of the Department of Immuno-Oncology at Beckman Research Institute at City of Hope, one of the largest and most advanced cancer research and treatment organizations in the United States, to raise awareness and funds for groundbreaking research on metastatic triple-negative breast cancer (mTNBC) using ivermectin.","length":479,"tagName":"p"},{"type":"text","content":"Through its subsidiaries, Simply Whim and Music of Your Life, The Marquie Group is supporting Dr. Lee’s innovative work by donating 10% of Simply Whim product sales to his research efforts. Additionally, the company will air a series of nationwide radio commercials on its Music of Your Life network, encouraging listeners to visit a dedicated City of Hope landing page to make tax-deductible donations directly to Dr. Lee’s research.","length":434,"tagName":"p"},{"type":"text","content":"CEO Marc Angell on Supporting this Research ","length":43,"tagName":"p"},{"type":"text","content":"Marc Angell, CEO of The Marquie Group, shared the personal motivation behind this initiative, “When the founder of Simply Whim was diagnosed with metastatic triple-negative breast cancer a few years ago, I reached out to Dr. Lee after reading about his incredible work with ivermectin. While ivermectin alone may not prevent cancer recurrence, Dr. Lee’s team has achieved positive results when combining it with other drugs.” Angell emphasized the importance of funding for such projects, “Dr. Lee noted that securing financial support is a constant challenge for these types of studies. By leveraging our radio network and collaborating with City of Hope, we aim to drive donations directly to his research. The team at City of Hope has been incredibly supportive in making this happen.”","length":788,"tagName":"p"},{"type":"text","content":"Dr. Peter P. Lee’s Research on TNBC with Ivermectin","length":51,"tagName":"p"},{"type":"text","content":"Dr. Lee and his team are now in the clinical trial phase, focusing on patients with a specific type of breast cancer known as “metastatic triple-negative breast cancer” (mTNBC). This subtype of breast cancer is considered particularly aggressive and has relatively limited treatment options, maki...